InvestorsHub Logo
Followers 28
Posts 4829
Boards Moderated 3
Alias Born 04/05/2017

Re: None

Thursday, 10/19/2017 4:14:41 PM

Thursday, October 19, 2017 4:14:41 PM

Post# of 33248
I don't like their use of the word speculative. This is even after they give a target price of .25 in the same article.


https://finance.yahoo.com/news/seethruequity-issues-note-endonovo-therapeutics-130000477.html?.tsrc=rss


We see ENDV as a "speculative" pre-clinical company in the biotechnology sector seeking to target a large market opportunity with its proprietary electroceutical products.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News